JPWO2021014172A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021014172A5
JPWO2021014172A5 JP2022504580A JP2022504580A JPWO2021014172A5 JP WO2021014172 A5 JPWO2021014172 A5 JP WO2021014172A5 JP 2022504580 A JP2022504580 A JP 2022504580A JP 2022504580 A JP2022504580 A JP 2022504580A JP WO2021014172 A5 JPWO2021014172 A5 JP WO2021014172A5
Authority
JP
Japan
Prior art keywords
compound
carboxamide
acetyl
pyridine
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022504580A
Other languages
English (en)
Japanese (ja)
Other versions
JP7682850B2 (ja
JP2022541638A5 (https=
JP2022541638A (ja
Publication date
Priority claimed from GBGB1910608.7A external-priority patent/GB201910608D0/en
Application filed filed Critical
Publication of JP2022541638A publication Critical patent/JP2022541638A/ja
Publication of JPWO2021014172A5 publication Critical patent/JPWO2021014172A5/ja
Publication of JP2022541638A5 publication Critical patent/JP2022541638A5/ja
Application granted granted Critical
Publication of JP7682850B2 publication Critical patent/JP7682850B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022504580A 2019-07-24 2020-07-24 カルシウム活性化クロライドチャネルモジュレーターとしてのピリジン誘導体 Active JP7682850B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1910608.7 2019-07-24
GBGB1910608.7A GB201910608D0 (en) 2019-07-24 2019-07-24 Compounds
PCT/GB2020/051785 WO2021014172A1 (en) 2019-07-24 2020-07-24 Pyridine derivatives as calcium-activated chloride channel modulators

Publications (4)

Publication Number Publication Date
JP2022541638A JP2022541638A (ja) 2022-09-26
JPWO2021014172A5 true JPWO2021014172A5 (https=) 2023-07-25
JP2022541638A5 JP2022541638A5 (https=) 2023-07-25
JP7682850B2 JP7682850B2 (ja) 2025-05-26

Family

ID=67839705

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022504580A Active JP7682850B2 (ja) 2019-07-24 2020-07-24 カルシウム活性化クロライドチャネルモジュレーターとしてのピリジン誘導体

Country Status (6)

Country Link
US (1) US12545658B2 (https=)
EP (1) EP4003977B1 (https=)
JP (1) JP7682850B2 (https=)
CN (1) CN114929683B (https=)
GB (1) GB201910608D0 (https=)
WO (1) WO2021014172A1 (https=)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2291749A1 (fr) * 1974-11-20 1976-06-18 Delalande Sa Nouveaux benzimidazoles acetiques, leur procede de preparation et leur application en therapeutique
US6262040B1 (en) * 1996-09-04 2001-07-17 Pfizer Inc Indazole derivatives and their use as inhibitors of phosphodiesterase (PDE) type IV and the production of tumor necrosis factor (TNF)
CA2419224A1 (en) * 2000-09-15 2002-03-21 Anormed Inc. Chemokine receptor binding heterocyclic compounds
US7642277B2 (en) * 2002-12-04 2010-01-05 Boehringer Ingelheim International Gmbh Non-nucleoside reverse transcriptase inhibitors
UY32138A (es) * 2008-09-25 2010-04-30 Boehringer Ingelheim Int Amidas sustituidas del ácido 2-(2,6-dicloro-fenilamino)-6-fluoro-1-metil-1h-bencimidazol-5-carboxílico y sus sales farmacéuticamente aceptables
US9550737B2 (en) * 2012-06-11 2017-01-24 Ucb Biopharma Sprl TNF -α modulating benzimidazoles
US9458124B2 (en) * 2013-02-06 2016-10-04 Wayne State University Substituted pyran derivatives
AU2016247768B2 (en) * 2015-04-17 2019-03-07 Corteva Agriscience Llc Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto
HUE064145T2 (hu) * 2016-04-15 2024-03-28 Epizyme Inc Amin-szubsztituált aril- vagy heteroaril vegyületek, mint EHMT1 és EHMT2 inhibitorok
GB201610854D0 (en) * 2016-06-21 2016-08-03 Entpr Therapeutics Ltd Compounds
GB201619694D0 (en) * 2016-11-22 2017-01-04 Entpr Therapeutics Ltd Compounds
AU2018211529A1 (en) * 2017-01-27 2019-08-29 Genfit N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxa zin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases
US11358947B2 (en) * 2017-04-17 2022-06-14 The Regents Of The University Of California Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel TMEM16A
GB201801355D0 (en) * 2018-01-26 2018-03-14 Enterprise Therapeutics Ltd Compounds

Similar Documents

Publication Publication Date Title
US11993581B2 (en) Pyridazine compounds for inhibiting Nav1.8
JP2021512143A5 (https=)
JP2021534124A5 (https=)
RU2402517C2 (ru) Пиразолы в качестве ингибиторов 11-бета-hsd-1
EP4051265A1 (en) Functionalized peptides as antiviral agents
CA3093851A1 (en) Substituted 1,1'-biphenyl compounds, analogues thereof, and methods using same
JP2023537402A (ja) 抗ウイルス剤としての機能化ペプチド
HRP20230294T1 (hr) Modulatori tmem16a
JP2007519754A5 (https=)
JP2011504497A5 (https=)
JPWO2020033828A5 (https=)
RU2012116877A (ru) Соединения 2-пиридона, применяемые в качестве ингибиторов нейтрофильной эластазы
JP2014530900A5 (https=)
JP2013510883A5 (https=)
WO2000075113A1 (en) Novel heterocyclic carboxamide derivatives
CA2672373A1 (en) Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
JP2008509187A5 (https=)
JP4915715B2 (ja) フェニルピリダジン誘導体及びこれを含有する医薬
RU2018136888A (ru) Нафтиридины в качестве антагонистов интегрина
WO2001025190A1 (en) Novel diarylamide derivatives and use thereof as medicines
SG191305A1 (en) Heterocyclic compounds suitable for the treatment of dyslipidemia
US12435040B2 (en) 1,3-substituted cyclobutyl derivatives and uses thereof
JPWO2019145726A5 (https=)
RU2016121854A (ru) Производные гетероарила
JP2004524345A5 (https=)